LL schreef op 18 januari 2024 13:10:
verklaring koersval:
Jan 18 (Reuters) - German drugmaker Bayer AG is leaning against breaking up the conglomerate, rejecting pleas from investors amid the company's ongoing struggle to recover from its purchase of Monsanto, Bloomberg News reported on Thursday, citing people familiar with the matter.